Literature DB >> 12742808

Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity.

Bettie C G Voordouw1, Paul D van der Linden, Simon Simonian, Johan van der Lei, Miriam C J M Sturkenboom, Bruno H C Stricker.   

Abstract

BACKGROUND: Influenza-related morbidity and mortality have been extensively studied with hospital and reimbursement data. However, little is known about the effectiveness of the annual vaccination programs in generally healthy community-dwelling elderly. The objective of our study was to investigate the effectiveness of influenza vaccination in community-dwelling elderly during the 1996 to 1997 influenza epidemic.
METHODS: We performed a population-based cohort study using the computerized Integrated Primary Care Information database in the Netherlands. Subjects who were 65 years and older in 1996 with a permanent status in a practice in the source population were considered eligible for study participation. Two cohorts were defined on the basis of vaccination status. We estimated and compared all-cause mortality, pneumonia, and clinical influenza infection rates between the cohorts.
RESULTS: Influenza vaccination was associated with a significant reduction of morbidity and mortality in vaccinated elderly (relative risk [RR], 0.72; 95% confidence interval [CI], 0.60-0.87). Influenza infections decreased significantly in the vaccinated population (RR, 0.48; 95% CI, 0.26-0.91). Mortality was reduced significantly in elderly with comorbidity (RR, 0.67; 95% CI, 0.48-0.94). The risk reduction for pneumonia was nonsignificant (RR, 0.77; 95% CI, 0.55-1.07) but was temporally related to the peak influenza activity.
CONCLUSIONS: In this study, influenza vaccination was associated with decreased mortality and influenza infections in community-dwelling elderly. Our results indicate that, in a season of mild influenza activity and good antigenic match between vaccine strains and circulating strains, influenza vaccination reduced mortality in the vaccinated population. Our data support an annual vaccination strategy for all community-dwelling elderly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742808     DOI: 10.1001/archinte.163.9.1089

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  21 in total

1.  Health disparities and prevention: racial/ethnic barriers to flu vaccinations.

Authors:  Judy Y Chen; Sarah A Fox; Clairessa H Cantrell; Susan E Stockdale; Marjorie Kagawa-Singer
Journal:  J Community Health       Date:  2007-02

Review 2.  Stress and health: psychological, behavioral, and biological determinants.

Authors:  Neil Schneiderman; Gail Ironson; Scott D Siegel
Journal:  Annu Rev Clin Psychol       Date:  2005       Impact factor: 18.561

3.  Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.

Authors:  Lidia Brydak; Julie Roiz; Pascaline Faivre; Camille Reygrobellet
Journal:  Clin Drug Investig       Date:  2012-02-01       Impact factor: 2.859

Review 4.  Influenza vaccination in the elderly: impact on hospitalisation and mortality.

Authors:  Kristin L Nichol
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 5.  [Assessment, triage, and follow-up of a patient with: acute CAP COPD].

Authors:  K Faure
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

6.  Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people.

Authors:  Ben G Armstrong; Punam Mangtani; Astrid Fletcher; Sari Kovats; Anthony McMichael; Sam Pattenden; Paul Wilkinson
Journal:  BMJ       Date:  2004-08-15

Review 7.  Improving outcomes of elderly patients with community-acquired pneumonia.

Authors:  Félix Gutiérrez; Mar Masiá
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 8.  The management of community-acquired pneumonia in the elderly.

Authors:  Paola Faverio; Stefano Aliberti; Giuseppe Bellelli; Giulia Suigo; Sara Lonni; Alberto Pesci; Marcos I Restrepo
Journal:  Eur J Intern Med       Date:  2013-12-17       Impact factor: 4.487

9.  Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza: illustration for the Netherlands.

Authors:  Maarten J Postma; Annoesjka Novak; Huib W K F H Scheijbeler; Marlene Gyldmark; Marianne L L van Genugten; Jan C Wilschut
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

10.  Influenza vaccination and mortality: differentiating vaccine effects from bias.

Authors:  Bruce Fireman; Janelle Lee; Ned Lewis; Oliver Bembom; Mark van der Laan; Roger Baxter
Journal:  Am J Epidemiol       Date:  2009-07-22       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.